SB 1565 – Stem Cell Research and Cures Act 

Author - Sheila Kuehl (D-Santa Monica)

CHI Position - Oppose

Summary - The bill would require that intellectual property standards that the ICOC develops shall include a requirement that each grantee and the licensees of the grantee submit to the CIRM for approval a plan that will afford uninsured Californians access to any drug that is, in whole or in part, the result of research funded by the CIRM, and would require that any plan subject to that approval shall require that the grantees and licensees thereof sell drugs at a price that does not exceed any benchmark price in the California Discount Prescription Drug Program.

Status - Passed Senate Floor on 05/15/08.  Passed Assembly Health on 06/17/08.  Passed Assembly Judiciary Committee on 06/24/08.  Awaiting Hearing in Assembly Appropriations Committee.

Link to legislation